Anaplastic lymphoma kinase as a new therapeutic target in inflammatory itch

被引：0
|
作者：
Voisin, Tiphaine [1 ]
Labit, Elodie [1 ]
Gaudenzio, Nicolas [1 ,2 ]
Basso, Lilian [1 ]
机构：
[1] Univ Toulouse III, Toulouse Inst Infect & Inflammatory Dis Infin, INSERM UMR1291, CNRS UMR5051, Toulouse, France
[2] Genoskin SAS, Toulouse, France
来源：
ALLERGY | 2024年
基金：
欧洲研究理事会;
关键词：
GASTRIN-RELEASING-PEPTIDE; RECEPTOR;
D O I：
10.1111/all.16260
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] ANAPLASTIC LYMPHOMA KINASE GENE COPY NUMBER GAIN IN INFLAMMATORY BREAST CANCER
    Kim, M. H.
    Sohn, J. H.
    Koo, J. S.
    Park, I. H.
    Jung, K. H.
    Lee, S.
    ANNALS OF ONCOLOGY, 2013, 24 : 25 - 25
  • [42] Anaplastic Lymphoma Kinase Positive Mesenteric Inflammatory Myofibroblastic Tumor in Adult Woman
    Lee, Christina S.
    Kim, Jason S.
    Rodriguez, Rosemarie
    Krell, Robert W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [43] Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis
    Chun, YS
    Wang, LN
    Nascimento, AG
    Moir, CR
    Rodeberg, DA
    PEDIATRIC BLOOD & CANCER, 2005, 45 (06) : 796 - 801
  • [44] Inflammatory myofibroblastic tumour of the testis with confirmed anaplastic lymphoma kinase gene rearrangement
    Hickman, Richard A.
    Alexander, Melissa
    Provet, John
    Melamed, Jonathan
    Deng, Fang-Ming
    HISTOPATHOLOGY, 2016, 68 (07) : 1109 - 1111
  • [45] Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy
    Rao, Karishma
    Farooki, Sana
    Guest, Erin
    Chastain, Katherine
    Gener, Melissa
    Akangire, Gangaram
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E521 - E524
  • [46] Anaplastic lymphoma kinase (ALK) protein overexpression is not a feature of inflammatory breast cancer
    Colpaert, Cecile
    Marsan, Melike
    Vermeulen, Peter
    Dirix, Luc
    Van Laere, Steven
    CANCER RESEARCH, 2015, 75
  • [47] Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1)
    Weiss, Joseph B.
    Raber, Jacob
    CANCERS, 2023, 15 (18)
  • [48] Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer
    Younes, MN
    Kim, S
    Yigitbasi, OG
    Mandal, M
    Jasser, SA
    Yazici, YD
    Schiff, BA
    El-Naggar, A
    Bekele, BN
    Mills, GB
    Myers, JN
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (08) : 1146 - 1156
  • [49] Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma
    Gadage, Vijaya S.
    Subramanian, P. G.
    Galani, Komal S.
    Sehgal, Kunal K.
    Johari, Sachin P.
    Ghogale, Vijay S.
    Badrinath, Y.
    Ashok, K.
    Gujral, Sumeet
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (03) : 599 - 602
  • [50] Expanding the portfolio of anaplastic lymphoma kinase inhibitors for anaplastic lymphoma kinase-rearranged lung cancers
    Santini, Fernando C.
    Salhab, Renata M.
    Sharma, Shorabh
    Drilon, Alexander
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1418 - S1421
12345